Healthcare -
Biotechnology - NASDAQ - US
$ 1.1857
-0.361 %
$ 65.3 M
Market Cap
-0.67
P/E
PRLD - OPERATING EXPENSES
Operating Expenses PRLD - Prelude Therapeutics Incorporated
132 M
LAST VALUE
7.84%
2 YEAR CAGR
54.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR